Bioprocessing scientist in a lab moving liquid with a pipette.

3M Purification and Contaminant Removal Solutions

Drive efficiency in your biopharmaceutical manufacturing process.

Optimize biopharmaceutical manufacturing with novel technologies.

Process-related impurity and bioburden control is critical in the biomanufacturing process. With continuously increasing demand to deliver high-quality biopharmaceuticals at an accelerated speed to market, manufacturers needs solutions that work through the entire process. 3M has proven solutions and expertise that help you address HCP reduction, viral clearance and bioburden control for a variety of applications leveraging membrane and chromatographic technologies.

A 3M™ Polisher ST and a competitor polisher side by side to call out obvious differences.
Purification. Simplified.

3M™ Polisher ST is the next generation in single-use anion exchange technology, designed as a cost-efficient option to increase yields in therapeutic recombinant protein processing.

Looking to improve your anion exchange unit operation? 3M™ Polisher ST offers the flexibility to operate in a wide range of conditions and can replace anion exchange polishing columns or membrane absorbers in fed batch and/or continuous manufacturing processes. 3M™ Polisher ST is a compact solution with greater capacity for delivering higher purity and yield in the downstream polishing unit operation.

Benefits of 3M™ Polisher ST

  • Icon of two stacked arrow heads pointing up.
    Increased yields: >95% mAb recovery.
  • Icon of two stacked carets pointing up.
    Higher purity: Robust removal of process and product related contaminants in a wide range of operating conditions.
  • Icon of a bar graph of ascending columns with an increasing trendline.
    Process intensification: Enables elimination of post viral inactivation (VI) depth and membrane filters.

See what industry experts say about 3M™ Polisher ST.

  • Cover of article.

    Many industry experts participated in the 3M™ Polisher ST beta test program and found that one of the key benefits is its performance across all tested process conditions. Its disposability, speed and ease of use were also key advantages. Find out more about major benefits hailed by expert panelists.

    View the Virtual Think Tank article — US, English only (PDF, 549 KB)


3M™ Polisher ST: A game-changer in polishing.


A synthetic, fully encapsulated single-use AEX device containing two complementary AEX-functionalized media.

  • A scanning electron microscopy showing the nonwoven fibre.

    AEX-functionalized non-woven fibre.

    Four layers of Q functionalized non-woven fibre provide reduction of turbidity (when present), DNA and endotoxin. These layers can also provide a portion of the product’s AEX capacity for HCP and virus reduction.

  • A scanning electron microscopy showing the membrane.

    AEX-functionalized membrane.

    Three layers of guanidinium-functionalized membrane provide HCP and viral reduction in a salt tolerant manner compared with conventional Q-functional technologies.


Meet the novel guanidinium ligand.

The novel guanidinium functionality of the downstream AEX polishing membrane mimics arginine, one of three positively charged standard amino acids that make up proteins. It can interact to form robust salt bridges that involve two hydrogen bonding interactions in addition to an electrostatic interaction.

This novel ligand enables robust impurity removal and viral clearance across a variety of conditions and its high density enables 50-100x higher mAb loading capacity than traditional chromatography resin beads.

  • Molecular structure of guanidinium ligand.
  • Interaction of protein carboxylate group with the guanidinium ligand.

Performance: Streamlined polishing and viral clearance.

Achieve robust HCP and viral clearance while increasing process yields.

  • Bar chart showing the mAb recovery in % at various pH levels by using 3M™ Polisher ST.

    mAb Recovery

    Without significant adjustments to pH and conductivity, 3M™ Polisher ST has robust performance with respect to HCP and DNA clearance and better mAb recovery.

  • Bar chart showing the HCP reduction in % at various pH level by using 3M™ Polisher ST.

    HCP Reduction

    • Approximately 500 ppm HCP in a VIN mAb pool
    • More than 60% removal in Phosphate buffer
    • More than 22% removal in Citrate buffer

Robust viral clearance.

3M™ Polisher ST removes HCP and DNA and is also an effective virus removal step as part of an orthogonal viral clearance technology platform. AEX performance of the guanidinium-functional membrane of 3M™ Polisher ST provides HCP and virus reduction in a salt tolerant (ST) manner.

  • Cover of test data report.

    3M™ Polisher ST Brochure

    Robust viral clearance is achieved over a range of buffer and pH conditions, which provide a wide design space for operation. Performance is maintained at high conductivity (20 mS/cm) even in citrate buffer, which reduces the need for feed dilution or buffer exchange requirement resulting in a simplified process with reduced cost factors.

    Read the test data here (PDF, 6.7 MB)


  • Cover of the paper.

    See results for streamlined polishing and viral clearance.

    Learn about the potential for simplification of downstream polishing. Our results show the capability to replace complex, buffer hungry, condition-limiting AEX resin columns with simple, small-footprint, single-use chromatography devices. These devices offer a high degree of flexibility in buffer types and fluid conditions, providing HCP and viral clearance even in the presence of turbidity. Investigators working with prototypes of the single-use AEX device have also been able to simplify their MAb purification processes significantly in turbid post-viral inactivation fluids by eliminating a unit process and avoiding the process fluid dilution required for an alternative commercial, non-salt tolerance AEX single-use device.

    Read the paper — US, English only (PDF, 974 KB)



Ask an expert

Fill out this form for any technical, business or process-related question, and an appropriate 3M Biopharmaceutical representative will contact you to answer your question or direct your request. ​

Request a sample

Fill out this form and a 3M Biopharmaceutical representative will contact you to help you select and receive a sample or trial based on your needs.


Two biopharmaceutical processing filters.
Membrane Filtration

Advanced pleat technology enables high capacity and sterilizing grade filters for biopharmaceutical manufacturing processes.

Biopharmaceutical membrane filters overview.

3M™ LifeASSURE™ Filters are ideal for biopharmaceutical manufacturing applications where low protein binding is critical. Our 3M series of membrane filters are optimized for both high-throughput and fast-flow applications. Our membrane filters offer 0.1pm and 0.2pm absolute rated filtration and increased effective filtration area (EFA) due to our Advance Pleat Technology (APT).

  • Icon of two cupped hands with the Red Cross symbol above.
    Sterile filtration.
  • Icon of two stacked arrow heads pointing up.
    High throughput enabled by advanced pleat technology.
  • Icon of four lines with arrows pointing outward from a singular point at forty-five degree angles.
    High contaminant capacity.
  • Icon of water flowing.
    Fast flow rate.

3M™ LifeASSURE™ Products are suited for a variety of applications.

    • Cell culture media and additives​
    • Serum​
    • Vaccines​
    • Pharmaceutical bulk chemical solutions​
    • Intermediate process filtration​
    • Buffers

Membrane Filtration FAQs

See all 3M™ LifeASSURE™ filters
  • What is a membrane filter?
    Membrane filters are a physical barrier with a defined pore size, or absolute rating, that allows particles smaller than that pore size to flow through into the permeate, while particles that are larger remain in the retentate, or feed side, of the membrane.
  • Sterile is defined as a validated condition or process that results in the complete exclusion and removal of all live microbes in a product [1]. Bioburden is the quantification for identifying the population number of viable micro-organisms in a product sample prior to sterile filtration [1]. Since classification of a sterilizing grade filter by pore size has limited value, the determination is defined by the filter’s bacterial retention performance. Therefore, a sterilizing grade membrane will reproducibly remove 100% of a test microbial contaminant while a bioburden reduction membrane will reduce the microbial level down to a pre-determined amount that is suitable for a process to handle.
  • Membranes can be constructed from a range of materials from polymers to metal to ceramics. For biopharmaceutical applications, the material choices include polyamide (nylon), polyethersulfone (PES), polytetrafluoroethylene (PTFE), polyvinylidene fluoride (PVDF), cellulose acetate, cellulose nitrate and polypropylene (PP).
  • For a mAb process, microfiltration membranes are used to pre-condition buffers and media before they are fed into various unit operations, as well as before and after chromatographic steps and at the end of the purification process before fill and finish. Ultrafiltration membrane filters are also used in the ultrafiltration/diafiltration (UF/DF) steps.
  • References
    1. Parenteral Drug Association, PDA J. Pharma. Sci. Technol., Technical Report No. 26 – Sterilising Filtration of Liquids, 2008, 62, No. S-5

Need help choosing the right product for the job?​

Get help with finding the optimal 3M biopharmaceutical solution for your application. Our experts can work with you to find products that will work with your process.

Ask an Expert

Fill out this form for any technical or process-related question, and an appropriate 3M Biopharmaceutical representative will contact you to answer your question or direct your request.


Find 3M biopharmaceutical solutions.

  • Find solutions for cell culture purification while driving efficiency whether you are using depth filtration or fibre chromatographic clarification.

  • Find solutions for more efficient bioprocessing across our portfolio.


Explore Applications

  • One step can transform your mAb and recombinant protein manufacturing process. At 3M, we’re helping build better, more efficient and simpler manufacturing processes by developing solutions to enhance biologic drug recovery that leads to improved process economics.​

  • Gene therapy is a fast-changing, promising field with new challenges for manufacturing and separation. Learn how we can help with our technologies and expertise.

  • Plasma fractionation has existed for decades, but additional separation methods are becoming increasingly common. We offer a range of products to help you with your process.

  • Getting the most out of your manufacturing process with speed and on budget is an increasing challenge. Our solutions may help you develop manufacturing processes for vaccines to help maximize purity, leading to overall process economics.​

  • If you need solutions for catalyst removal and recovery, colour removal, particulate filtration and fill-finish, 3M offers a wide range of adsorptive depth filters and membrane products for application in the chemical pharmaceutical manufacturing. 


Laptop displaying an online sign up forms for notifications.
Stay up to date on the latest news and product information.
SUBSCRIBE